These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 34669519)

  • 1. Transcriptomic Landscape of Gene Expression Profiles and Pathways in Juvenile-Onset Recurrent Respiratory Papillomatosis Tumor Tissues and Human Papillomavirus 6 and 11 E6- and E7-Overexpressing Head and Neck Squamous Cell Carcinoma Cell Lines.
    Wu X; Xiao Y; Zhou S; Wang Y; Wang J
    J Virol; 2022 Jan; 96(2):e0134221. PubMed ID: 34669519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HPV type determination and clinical characteristics in juvenile onset recurrent respiratory papillomatosis].
    Yang ML; Wang J; Xiao Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):730-732;736. PubMed ID: 29771024
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia.
    Danielewski JA; Garland SM; McCloskey J; Hillman RJ; Tabrizi SN
    PLoS One; 2013; 8(5):e63892. PubMed ID: 23691108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced NK Cell Cytotoxicity by Papillomatosis-Derived TGF-β Contributing to Low-Risk HPV Persistence in JORRP Patients.
    Wu X; Xiao Y; Guo D; Zhang Z; Liu M
    Front Immunol; 2022; 13():849493. PubMed ID: 35350785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile onset recurrent respiratory papillomatosis: What do we know in 2024 ?
    Lepine C; Leboulanger N; Badoual C
    Tumour Virus Res; 2024 Jun; 17():200281. PubMed ID: 38685530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of low risk human papillomaviruses, HPV6 and HPV11 in laryngeal papillomatosis in Burkina Faso.
    Ilboudo M; Zohoncon TM; Traore IMA; Traore EMA; Kande A; Obiri-Yeboah D; Djigma FW; Gyebre YMC; Simpore J
    Am J Otolaryngol; 2019; 40(3):368-371. PubMed ID: 30799210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of robust cellular immunity against HPV6 and HPV11 in mice by DNA vaccine encoding for E6/E7 antigen.
    Shin TH; Pankhong P; Yan J; Khan AS; Sardesai NY; Weiner DB
    Hum Vaccin Immunother; 2012 Apr; 8(4):470-8. PubMed ID: 22336879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of human papillomavirus oncoproteins E6 and E7 inhibits invadopodia activity but promotes cell migration in HPV-positive head and neck squamous cell carcinoma cells.
    Kahue CN; Jerrell RJ; Parekh A
    Cancer Rep (Hoboken); 2018 Oct; 1(3):e1125. PubMed ID: 32721084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV Strain Predicts Severity of Juvenile-Onset Recurrent Respiratory Papillomatosis with Implications for Disease Screening.
    Bedard MC; de Alarcon A; Kou YF; Lee D; Sestito A; Duggins AL; Brusadelli M; Lane A; Wikenheiser-Brokamp KA; Wells SI; Smith DF
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34070981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV genotype is a prognosticator for recurrence of respiratory papillomatosis in children.
    Nogueira RL; Küpper DS; do Bonfim CM; Aragon DC; Damico TA; Miura CS; Passos IM; Nogueira ML; Rahal P; Valera FCP
    Clin Otolaryngol; 2021 Jan; 46(1):181-188. PubMed ID: 32869523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11.
    Tjon Pian Gi RE; San Giorgi MR; Slagter-Menkema L; van Hemel BM; van der Laan BF; van den Heuvel ER; Dikkers FG; Schuuring EM
    Head Neck; 2015 Nov; 37(11):1625-32. PubMed ID: 24955561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV
    Brand TM; Hartmann S; Bhola NE; Peyser ND; Li H; Zeng Y; Isaacson Wechsler E; Ranall MV; Bandyopadhyay S; Duvvuri U; LaVallee TM; Jordan RCK; Johnson DE; Grandis JR
    Clin Cancer Res; 2017 Jun; 23(12):3072-3083. PubMed ID: 27986750
    [No Abstract]   [Full Text] [Related]  

  • 13. EGFR-induced suppression of HPV E6/E7 is mediated by microRNA-9-5p silencing of BRD4 protein in HPV-positive head and neck squamous cell carcinoma.
    Nantajit D; Presta L; Sauter T; Tavassoli M
    Cell Death Dis; 2022 Nov; 13(11):921. PubMed ID: 36333293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenes.
    Oh JE; Kim JO; Shin JY; Zhang XH; Won HS; Chun SH; Jung CK; Park WS; Nam SW; Eun JW; Kang JH
    Int J Oncol; 2013 Aug; 43(2):383-93. PubMed ID: 23708675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic responses to a novel DNA vaccine targeting human papillomavirus-11 E6E7.
    Ahn J; Peng S; Hung CF; Roden RBS; Wu TC; Best SR
    Laryngoscope; 2017 Dec; 127(12):2713-2720. PubMed ID: 28714529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-expression of low-risk HPV E6/E7 and EBV LMP-1 leads to precancerous lesions by DNA damage.
    Uehara K; Tanabe Y; Hirota S; Higa S; Toyoda Z; Kurima K; Kina S; Nakasone T; Arasaki A; Kinjo T
    BMC Cancer; 2021 Jun; 21(1):688. PubMed ID: 34112111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Association between Human Papillomavirus Types 6 and 11 Genetic Variants and Cervical Abnormalities: The Ludwig-McGill Cohort Study.
    Sichero L; El-Zein M; Ferreira S; Franco EL; Villa LL;
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1086-1088. PubMed ID: 30867221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of anti-HPV11-L1 antibodies in immune sera from patients suffering from recurrent respiratory papillomatosis using ELISA.
    Durzyńska J; Błazejewska P; Szydłowski J; Goździcka-Józefiak A
    Viral Immunol; 2010 Aug; 23(4):415-23. PubMed ID: 20712486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphoproteomics, E6/E7 in-situ hybridization, and biomedical analytics define the etiopathogenesis of HPV-associated oropharyngeal carcinoma and provide targeted therapeutic options.
    Brown RE; Naqvi S; McGuire MF; Buryanek J; Karni RJ
    J Otolaryngol Head Neck Surg; 2017 Aug; 46(1):52. PubMed ID: 28818106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic E6 and/or E7 proteins drive proliferation and invasion of human papilloma virus‑positive head and neck squamous cell cancer through upregulation of Ror2 expression.
    Avincsal MO; Kamizaki K; Jimbo N; Shinomiya H; Nibu KI; Nishita M; Minami Y
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34080643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.